QGEN
Qiagen N.V.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+35/100
Last price
44.79
▼ 0.86 (1.88%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
45.85
Prev close
45.65
Day high
46.09
Day low
44.78
Volume
2.58M
Market cap
$9.25B
P/E (TTM)
22.74
52W range
32.53 – 57.82
Day trading desk
Gap from prior close
+0.44%
Prior close 45.65
VWAP
45.30
-1.12% from price
Relative volume
2.73×
Unusually busy
Session range
2.93%
44.78 – 46.09
Position in range
1%
Near session low
ATR (14D)
1.50
3.35% of price
Prior day high
47.28
PDH
Prior day low
45.27
PDL
Bid / ask spread
—
Quote not published
Session volume
7.51M
Avg 2.75M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.35%
+0.4%
1M
+5.69%
+4.2%
3M
+6.67%
+3.3%
6M
+8.53%
-6.4%
YTD
-0.40%
-14.4%
1Y
-4.62%
-20.3%
3Y
+8.42%
-73.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on QGEN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
993.24K
Total on file
Fundamentals
Market cap$9.25B
Enterprise value$10.29B
Revenue (TTM)$2.10B
Gross profit$1.39B
EBITDA$734.19M
Net income$409.32M
EPS (TTM)$1.97
Free cash flow$372.86M
Total cash$793.50M
Total debt$1.65B
Book value / share$16.26
Shares outstanding206.50M
Float205.17M
Short % of float4.20%
Dividend yield0.77%
Beta (5Y)0.61
Valuation & profitability ratios
Trailing P/E22.74
Forward P/E17.14
PEG ratio1.22
Price / sales—
Price / book2.75
EV / revenue4.90
EV / EBITDA14.01
Gross margin66.39%
Operating margin26.32%
Profit margin19.49%
Return on equity11.93%
Return on assets5.87%
Debt / equity49.25
Current ratio2.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.09B | $1.98B | $1.97B | $2.14B | +5.7% |
| Operating revenue | $2.09B | $1.98B | $1.97B | $2.14B | +5.7% |
| Cost of revenue | $790.50M | $1.01B | $731.62M | $756.96M | -21.8% |
| Gross profit | $1.30B | $967.35M | $1.23B | $1.38B | +34.3% |
| Research & development | $187.52M | $193.49M | $198.51M | $189.86M | -3.1% |
| Selling, general & admin | $583.67M | $564.36M | $579.17M | $603.95M | +3.4% |
| Total operating expense | $779.18M | $767.45M | $788.44M | $808.34M | +1.5% |
| Operating income | $520.31M | $199.90M | $445.25M | $576.23M | +160.3% |
| Net interest income | $31.06M | $24.18M | $25.58M | -$25.60M | +28.5% |
| Pre-tax income | $490.26M | $121.15M | $429.81M | $512.60M | +304.7% |
| Tax provision | $65.39M | $37.56M | $88.51M | $89.39M | +74.1% |
| Net income | $424.88M | $83.59M | $341.30M | $423.21M | +408.3% |
| Net income to common | $424.88M | $83.59M | $341.30M | $423.21M | +408.3% |
| Basic EPS | 2.06 | 0.41 | 1.67 | 2.82 | +406.7% |
| Diluted EPS | 2.04 | 0.40 | 1.65 | 2.79 | +409.8% |
| EBIT | $523.52M | $164.99M | $483.22M | $570.96M | +217.3% |
| EBITDA | $717.27M | $368.26M | $688.55M | $779.36M | +94.8% |
| Basic shares | 206.36M | 205.31M | 204.45M | 203.89M | +0.5% |
| Diluted shares | 207.94M | 207.55M | 206.61M | 206.18M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $839.00M | $663.55M | $668.08M | $730.67M | — | +26.4% |
| Cash & short-term investments | $1.10B | $1.15B | $1.06B | $1.42B | — | -4.7% |
| Accounts receivable | $402.61M | $349.28M | $381.88M | $323.75M | — | +15.3% |
| Inventory | $301.89M | $279.26M | $398.38M | $357.96M | — | +8.1% |
| Total current assets | $2.00B | $1.96B | $2.15B | $2.39B | — | +1.8% |
| Property, plant & equipment | $1.08B | $753.61M | $765.04M | $662.17M | — | +42.9% |
| Goodwill & intangibles | $3.09B | $2.73B | $3.00B | $2.90B | — | +13.1% |
| Total assets | $6.28B | $5.69B | $6.12B | $6.29B | — | +10.4% |
| Total current liabilities | $512.14M | $1.04B | $1.08B | $974.52M | — | -50.9% |
| Current debt | — | $551.88M | $587.97M | $389.55M | $847.63M | — |
| Long-term debt | $1.65B | $839.66M | $921.82M | $1.47B | — | +97.0% |
| Total debt | $1.81B | $1.51B | $1.53B | $1.88B | — | +19.8% |
| Total liabilities | $2.50B | $2.12B | $2.31B | $2.82B | — | +17.9% |
| Retained earnings | $2.75B | $2.45B | $2.46B | $2.16B | — | +12.3% |
| Shareholder equity | $3.78B | $3.57B | $3.81B | $3.47B | — | +5.9% |
| Working capital | $1.48B | $917.82M | $1.07B | $1.42B | — | +61.6% |
| Net tangible assets | $691.07M | $838.11M | $805.21M | $569.25M | — | -17.5% |
| Shares issued | 206.80M | 206.80M | 206.80M | 206.80M | — | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $424.88M | $83.59M | $341.30M | $423.21M | — | +408.3% |
| Depreciation & amortisation | $193.75M | $203.27M | $205.34M | $208.40M | — | -4.7% |
| Stock-based compensation | $50.40M | $43.63M | $47.10M | $49.51M | — | +15.5% |
| Change in working capital | -$34.51M | $135.45M | -$186.96M | -$31.88M | — | -125.5% |
| Operating cash flow | $654.33M | $673.55M | $459.45M | $715.26M | — | -2.9% |
| Capital expenditure | -$207.13M | -$171.24M | -$162.80M | -$149.34M | — | -21.0% |
| Investing cash flow | -$305.28M | -$249.23M | -$87.66M | -$726.76M | — | -22.5% |
| Share buybacks | — | -$292.10M | $0 | $0 | -$99.99M | — |
| Dividends paid | -$54.24M | $0 | $0 | — | — | — |
| Financing cash flow | -$178.98M | -$422.90M | -$433.83M | -$125.80M | — | +57.7% |
| Free cash flow | $447.20M | $502.31M | $296.65M | $565.93M | — | -11.0% |
| End cash position | $839.00M | $663.55M | $668.08M | $730.67M | — | +26.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $535.04M | $492.32M | $540.42M | $532.58M | $533.54M | +8.7% |
| Operating revenue | $535.04M | $492.32M | $597.72M | $514.91M | $533.54M | +8.7% |
| Cost of revenue | $194.65M | $182.72M | $215.15M | $201.32M | $199.25M | +6.5% |
| Gross profit | $340.39M | $309.60M | $325.27M | $331.26M | $334.29M | +9.9% |
| Research & development | $50.43M | $48.26M | $47.23M | $48.75M | $47.75M | +4.5% |
| Selling, general & admin | $146.77M | $142.39M | $153.88M | $143.11M | $148.75M | +3.1% |
| Total operating expense | $199.54M | — | — | — | — | — |
| Operating income | $140.85M | $116.63M | $121.88M | $137.29M | $135.97M | +20.8% |
| Net interest income | -$661.00K | -$489.00K | $9.86M | $6.85M | $6.25M | -35.2% |
| Pre-tax income | $132.10M | $85.83M | $109.17M | $134.73M | $126.82M | +53.9% |
| Tax provision | $28.70M | $17.79M | $1.34M | $4.68M | $30.57M | +61.4% |
| Net income | $103.40M | $68.04M | $107.83M | $130.04M | $96.25M | +52.0% |
| Net income to common | $103.40M | $68.04M | $107.83M | $130.04M | $96.25M | +52.0% |
| Basic EPS | 0.50 | 0.33 | 0.52 | 0.63 | 0.46 | +51.5% |
| Diluted EPS | 0.50 | 0.33 | 0.52 | 0.63 | 0.46 | +51.5% |
| EBIT | $142.13M | $96.88M | $119.31M | $142.94M | $134.43M | +46.7% |
| EBITDA | $192.68M | $148.09M | $168.70M | $193.91M | $183.90M | +30.1% |
| Basic shares | 206.35M | 207.01M | 206.07M | 206.03M | 205.87M | -0.3% |
| Diluted shares | 207.83M | 208.94M | 207.76M | 207.53M | 207.27M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $768.50M | $646.29M | $839.00M | $1.36B | $733.82M | — | +18.9% |
| Cash & short-term investments | $793.50M | $646.29M | $1.10B | $1.69B | $953.82M | — | +22.8% |
| Accounts receivable | $389.85M | $396.62M | $402.61M | $375.56M | $385.76M | — | -1.7% |
| Inventory | $311.36M | $309.61M | $301.89M | $290.23M | $292.55M | — | +0.6% |
| Total current assets | $1.66B | $1.54B | $2.00B | $2.53B | $1.82B | — | +7.6% |
| Property, plant & equipment | $923.04M | $914.79M | $1.08B | $897.64M | $874.95M | — | +0.9% |
| Goodwill & intangibles | $3.05B | $3.06B | $3.09B | $2.85B | $2.87B | — | -0.6% |
| Total assets | $5.89B | $5.78B | $6.28B | $6.55B | $5.82B | — | +1.9% |
| Total current liabilities | $581.45M | $479.11M | $512.14M | $973.40M | $1.13B | — | +21.4% |
| Current debt | $16.52M | — | — | $499.60M | $559.19M | $55.69M | — |
| Long-term debt | $1.63B | $1.65B | $1.65B | $1.63B | $884.85M | — | -1.2% |
| Total debt | $1.64B | $1.65B | $1.81B | $2.13B | $1.44B | — | -0.2% |
| Total liabilities | $2.53B | $2.45B | $2.50B | $2.90B | $2.32B | — | +3.3% |
| Retained earnings | $2.81B | $2.80B | $2.75B | $2.65B | $2.52B | — | +0.5% |
| Shareholder equity | $3.36B | $3.33B | $3.78B | $3.65B | $3.51B | — | +0.8% |
| Working capital | $1.08B | $1.06B | $1.48B | $1.56B | $690.67M | — | +1.3% |
| Net tangible assets | $312.00M | $268.24M | $691.07M | $797.76M | $639.26M | — | +16.3% |
| Shares issued | 206.50M | 206.80M | 206.80M | 206.80M | 206.80M | — | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $103.40M | $68.04M | $107.83M | $130.04M | $96.25M | +52.0% |
| Depreciation & amortisation | $50.55M | $51.21M | $49.39M | $50.97M | $49.48M | -1.3% |
| Stock-based compensation | $6.97M | $9.65M | $16.59M | $10.71M | $10.76M | -27.8% |
| Change in working capital | $38.93M | -$42.14M | $10.64M | -$26.42M | -$4.13M | +192.4% |
| Operating cash flow | $200.69M | $100.63M | $188.13M | $165.02M | $161.44M | +99.4% |
| Capital expenditure | -$43.37M | -$48.48M | -$71.58M | -$50.45M | -$40.84M | +10.6% |
| Investing cash flow | -$70.26M | $211.47M | -$226.47M | -$156.90M | -$42.00M | -133.2% |
| Share buybacks | — | — | — | $0 | — | — |
| Dividends paid | — | — | $1.00K | — | — | — |
| Financing cash flow | -$8.47M | -$503.66M | -$478.35M | $614.07M | -$27.99M | +98.3% |
| Free cash flow | $157.32M | $52.15M | $116.55M | $114.57M | $120.60M | +201.7% |
| End cash position | $768.50M | $646.29M | $839.00M | $1.36B | $733.82M | +18.9% |
Options analytics
Put / call volume
0.06
Call-heavy session
Put / call open interest
0.48
Positioning, not flow
Max pain
45.00
+0.5% from spot
ATM implied vol
60.8%
Nearest strike to spot
Skew (10% OTM)
-18.9%
Calls bid over puts
Call volume
1.00K
Contracts, this expiry
Put volume
63
Contracts, this expiry
Heaviest call OI
45.00
3.71K contracts
Heaviest put OI
40.00
2.95K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.60 | 0.62 | +3.5% |
| Mar 2026 | 0.54 | 0.54 | 0.0% |
| Dec 2025 | 0.62 | 0.62 | +0.1% |
| Sep 2025 | 0.62 | 0.64 | +4.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.62 | 9 | $535.95M | +0.6% |
| Next quarter | 0.65 | 9 | $573.32M | +6.1% |
| Current year | 2.43 | 13 | $2.14B | +2.2% |
| Next year | 2.61 | 13 | $2.24B | +5.1% |
Analyst targets & ownership
Mean target$47.27
High target$55.00
Low target$40.00
Implied upside5.53%
Analyst count15
ConsensusBUY
Strong buy / Buy5 / 4
Hold7
Sell / Strong sell0 / 0
Held by insiders0.48%
Held by institutions79.16%
Institutions holding647
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
44.49
+0.67% from price
SMA 20
43.84
+2.18% from price
SMA 50
43.30
+3.45% from price
SMA 100
40.74
+9.93% from price
SMA 200
42.46
+5.49% from price
EMA 12
44.42
+0.83% from price
EMA 26
43.89
+2.05% from price
EMA 50
43.09
+3.94% from price
RSI (14)
54.2
Neutral
MACD (12,26,9)
0.53
Hist 0.11
ATR (14)
1.50
3.35% of price
Realised vol 30D
33.2%
Annualised
Bollinger upper
46.17
20, 2σ
Bollinger lower
41.51
20, 2σ
50 / 200 cross
Golden
43.30 vs 42.46
Trend bias
Above 200
+5.49%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.43
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
33.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-41.4%
Peak to trough
Max drawdown 5Y
-44.0%
Peak to trough
ATR 14
1.50
3.35% of price
Beta (reported)
0.61
5Y monthly, from filing
Short interest
Shares short
7.66M
Prior 10.14M
Change vs prior
-24.4%
Shorts covering
% of float
4.20%
Normal
% of shares out
3.71%
Against total outstanding
Days to cover
3.0
Liquid
Float
205.17M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | Barclays | UPGRADE | Equal-Weight | Overweight |
| Sep 9, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Aug 10, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 7, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jun 23, 26 | Morgan Stanley | UPGRADE | Equal-Weight | Overweight |
| May 18, 26 | Stifel | MAINTAINED | Hold | Hold |
| May 7, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Apr 29, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Apr 29, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Apr 29, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 29, 26 | Baird | UPGRADE | Neutral | Outperform |
Dividends & splits
Forward rate$0.35 / yr
Forward yield0.77%
5-year avg yield—
Payout ratio17.79%
Ex-dividend dateJul 7, 2026
Next pay dateJul 14, 2026
Last split962:1000
Split dateJan 25, 2017
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-09-09
Corporate Changes & Voting Matters
6-K · 2026-08-07
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Corporate Changes & Voting Matters
6-K · 2026-05-08
Corporate Changes & Voting Matters
6-K · 2026-05-01
Periodic Financial Reports
20-F · 2026-03-20
Corporate Changes & Voting Matters
6-K · 2026-02-06
Corporate Changes & Voting Matters
6-K · 2025-12-22
Headlines
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery
Business Wire · 1d ago
Barclays Upgrades QIAGEN to Overweight From Equalweight
MT Newswires · 1d ago
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
Zacks · 5d ago
Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen
GlobeNewswire · 7d ago
Qiagen (QGEN), What Is Behind The Fresh Attention Now?
Simply Wall St. · 9d ago
What Qiagen (QGEN)'s Expanded Sepsis Testing Portfolio Means For Shareholders
Simply Wall St. · 9d ago
Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership
GlobeNewswire · 10d ago
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel
Business Wire · 10d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.